Fundz

Humane Genomics raised an undisclosed amount in Seed funding led by Union Square Ventures to expand operations and development efforts.

PRIVATEFeb 21, 2025

Round Type

Seed

New YorkBiotechnologyHealth CareTherapeutics

Investors

Union Square Ventures

Description

Humane Genomics, a developer of precision-designed therapies based in NYC, has successfully completed a Seed funding round. The funds will be used for expanding operations and advancing their development efforts, particularly in creating oncolytic viruses targeting pediatric liver cancer.

Quick answer

Humane Genomics raised an undisclosed amount in a Seed round, dated February 21, 2025. Investors: Union Square Ventures. Humane Genomics is based in New York, New York, United States.

How much did Humane Genomics raise?
Humane Genomics raised an undisclosed amount in a Seed round on February 21, 2025.
Who invested in Humane Genomics?
Union Square Ventures is named as investors in this round.
What does Humane Genomics do?
Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency.
Where is Humane Genomics based and how big is it?
Humane Genomics is based in New York, New York, United States. Fundz records about 5 employees.
Who are the decision-makers at Humane Genomics?
Fundz holds 1 contact at Humane Genomics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Humane Genomics that raised within 45 days of this round, from Fundz verified event records.

  • Accure Therapeutics S.L raised $1.6M (Seed) on April 7, 2025.
  • Apeximmune Therapeutics raised $21M (Series A) on April 1, 2025.
  • Prazer Therapeutics raised $22M (Series B) on April 1, 2025.
  • NewcelX raised $2M (Seed) on March 28, 2025.
  • Epicrispr Biotechnologies raised $68M (Series B) on March 27, 2025.
  • Tribune Therapeutics raised $40M (Seed) on March 26, 2025.

Who to call at Humane Genomics, and when

A new round usually means Humane Genomics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Humane Genomics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Humane Genomics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Humane Genomics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Humane Genomics

Location

New York, New York, United States

About

Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency. Our first indication is liver cancer. We are based in New York City and backed by amazing investors. (YC S21)

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Humane Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Humane Genomics's next move

See what Strategic adds

Humane Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.